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The authors estimated the generalized impact fraction (GIF) for heart failure (HF) related to obesity, represent-
ing the proportion of incident HF events that could be prevented from reductions in obesity and/or overweight.
The Atherosclerosis Risk in Communities Study is a biracial population-based cohort study of persons aged
45–64 years from 4 US communities with a median 14 years of follow-up (1987–2003) for incident, hospitalized,
or fatal HF. Body mass index (BMI; weight (kg)/height (m)2) was measured at baseline (1987–1989) and cate-
gorized as normal weight (BMI <25), overweight (BMI 25–29.9), or obese (BMI 30). After exclusion of prevalent
HF, missing BMI, and poorly represented racial groups, the sample size was 14,642. The GIF and attributable
fraction were calculated using a case-load weighted-sum method. A 95% distribution of the GIF was estimated
from bootstrapped data sets. A 30% hypothetical reduction in obesity/overweight would potentially prevent 8.5%
(95% simulation interval: 6.1, 10.7) of incident HF events. The attributable fraction, which assumes complete
elimination of obesity/overweight, was 28% (95% simulation interval: 20, 36)—approximately 3 times larger than
the most optimistic GIF calculated here. Investigators studying exposures that are unlikely to be eradicated given
current prevention efforts, such as obesity, should consider estimating the GIF to avoid overestimates of pop-
ulation impact.
epidemiologic methods; heart failure; obesity; population dynamics
Abbreviations: AF, attributable fraction; ARIC, Atherosclerosis Risk in Communities; CI, confidence interval; GIF, generalized
impact faction; HR, hazard ratio.
Heart failure is common, with an estimated 5,300,000
American adults living with heart failure, and it is increasing
in prevalence (1). Hospital discharges for heart failure in the
United States have increased 171% since 1979, with 660,000
incident heart failure cases annually and nearly $35 billion in
US health-care costs (1). Clearly the prevention of heart fail-
ure must be a priority. The American Heart Association rec-
ognizes obesity as a qualifying risk factor for stage A heart
failure (2). The American Heart Association has released
a specific scientific statement on heart failure prevention; it
recommends maintenance of normal weight as one way to
prevent heart failure (3). The impact of a population-level
reduction in obesity on the potential prevention of heart fail-
ure has been assessed only in terms of the attributable fraction
(AF), which estimates the proportional reduction in disease
given complete elimination of an exposure (4, 5). For many
exposures (including obesity and overweight), complete
elimination is highly unlikely given our current methods for
prevention (6). Despite this, the AF has been used extensively
in the obesity literature, including recent studies estimating
the burden of all-cause mortality attributable to overweight
and obesity (7, 8).
Given that obesity is unlikely to be eliminated from so-
ciety, as assumed in calculations of the AF, a more realistic
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and meaningful calculation for estimating the impact of
weight reduction on disease incidence is the generalized
impact fraction (GIF), also known as the potential impact
fraction and the generalized AF (9, 10). It estimates the
proportional reduction in disease incidence given a graded
reduction in the prevalence of a risk factor; therefore, the AF
is simply a special case of the GIF in which complete elim-
ination of the risk factor is assumed. For common risk
factors and diseases, the impact of a hypothetical reduction
in the exposure may reveal an important effect on disease
incidence even when risk factor-disease associations are
relatively weak (11).
The GIF was originally described by Walter (12) in 1980
and then further elaborated on by Morgenstern and Bursic
(11) in 1982. Specifically, it is ‘‘the proportional reduction
in the total number of new (incident) cases of a certain
disease, resulting from a specific change in the distribution
of a risk factor in the population at risk’’ (11, p. 295). De-
spite its introduction over 25 years ago, it has not caught on
as either a replacement for or a complement to the AF. Re-
cent examples of its use come from research on the global
burden of disease (13), health policy (14), environmental
epidemiology (15), and nutritional epidemiology (16).
Our goal in this study was to estimate the population
burden of incident heart failure that would be prevented
from a feasible reduction in the prevalence of obesity and
overweight, through calculation of the GIF. We considered
several scenarios of reduced prevalence of obesity and over-
weight. In addition, we calculated the AF, using the same
method used to calculate the GIF, to compare this more
commonly used measure with the GIF.
MATERIALS AND METHODS
Study population
The Atherosclerosis Risk in Communities (ARIC) cohort
(n ¼ 15,792) was recruited between 1987 and 1989 using
probability sampling of persons aged 45–64 years from 4
US communities: Forsyth County, North Carolina; Jackson,
Mississippi; the northwestern suburbs ofMinneapolis,Minne-
sota; and Washington County, Maryland. The distribution of
blacks and whites from each field center was representative of
the area (mostly whites in Minneapolis and Washington
County, 15% blacks in Forsyth County), except in Jackson,
where only blacks were sampled. Response to the baseline
examination was 46% in Jackson and 65%–67% in the other
communities. Three subsequent examinationswere conducted
at approximately 3-year intervals through 1996–1998. The
design and rationale of the ARIC Study (17) and comparisons
between responders and nonresponders (18) have been pre-
viously published. The institutional review boards from each
study site approved the ARIC Study. Participants provided
written informed consent at each examination.
Racial groups not classified as white or black (n ¼ 48) and
blacks not from the city of Jackson or Forsyth County (n ¼
120) were excluded from the analyses because of their limited
numbers. Persons missing anthropometric data at baseline
were excluded (n¼ 33). Prevalent heart failure was excluded
by means of the following criteria: 1) persons reporting
medication use for heart failure (n ¼ 83); 2) persons with
a stage 3 Gothenburg score (n ¼ 699) (19); and 3) persons
missing data on criteria used to define prevalent heart failure
(n ¼ 289). After these exclusions, the total sample size was
14,399.
Anthropometric and study population characteristics
Body mass index was calculated as weight (kg) divided
by height squared (m2). Height and weight were measured
using standardized methods (20). All measurements and
characteristics were from the baseline visit. Race, gender,
educational level, alcohol use, and smoking status were ob-
tained by participant self-report. A history of coronary heart
disease included prior myocardial infarction (either a self-
report of physician-diagnosed myocardial infarction or
silent myocardial infarction as identified by electrocardiog-
raphy) or a prior coronary revascularization procedure or
coronary artery bypass surgery. Hypertension was defined
as either a measured diastolic blood pressure90 mm Hg or
a measured systolic blood pressure 140 mm Hg or recent
use of antihypertensive medication. Diabetes mellitus was
defined as any of the following: self-reported history of
physician-diagnosed diabetes, recent use of medication for
diabetes, fasting blood glucose concentration 126 mg/dL,
or nonfasting blood glucose concentration 200 mg/dL.
Ascertainment of heart failure events
The following methods were used for ascertainment of
heart failure events: 1) participants were contacted annually
by telephone and interviewed about interim hospitaliza-
tions; 2) local hospitals provided lists of hospital discharges
with cardiovascular diagnoses, and these were reviewed to
identify cohort hospitalizations; and 3) health department
death certificate files were continuously surveyed. All dis-
charge codes for cohort hospitalizations and listed causes of
death from death certificates were recorded (underlying
cause of death or contributory causes).
Criteria for an incident heart failure event
Incident heart failure was defined according to Interna-
tional Classification of Diseases codes for a hospitalization
(n¼ 1,329) or death (n¼ 76) (International Classification of
Diseases, Ninth Revision, Clinical Modification, code 428.x
or International Classification of Diseases, Tenth Revision,
code I50), as previously described (20). Follow-up for inci-
dent heart failure eventswas defined as time from the baseline
examination to the incident event, with follow-up through
December 31, 2003. The end of follow-up for personswithout
heart failure was the first occurrence of either 1) December
31, 2003, 2) the date of last contact, or 3) the date of death.
Estimates for reduced prevalence of obesity and
overweight
To determine feasible goals for weight reduction, we con-
sidered the goals set by the US Department Health and
Human Services in the Healthy People 2010 report (21).
Healthy People 2010 is a set of recommended health
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objectives that were meant to serve as a basis from which to
develop plans for health improvement by the year 2010. Obe-
sity and overweight are listed as high-priority public health
issues. Specifically, their aim is to reduce the proportion of
obese adults aged 20 years or older to 15% from 23%, which
is approximately a 35% reduction in the proportion of adults
who are obese. For this study, several scenarios were selected
for a reduction in obesity and overweight, for which the
maximum achievable goal was a 30% reduction in both obe-
sity and overweight. Reductions of 30% for each subgroup
were targeted, rather than a 15% prevalence of obesity for all
subgroups, since certain groups with high rates of obesity,
such as black women, would require an impractical amount
of widespread weight reduction to meet this goal.
Statistical methods
The GIF and the AF were estimated using Appendix
equations 1 and 2 (GIF) and Appendix equations 2 and 3
(AF), respectively (11). Specifically, the GIF and AF were
calculated for each age-, race-, and gender-stratified group
(equation 1 or 2 in the Appendix) and then combined using
a case-load weighted sum method for an overall GIF and AF
(equation 2 in the Appendix). Cox proportional hazards re-
gression was used to model the associations between obesity
(body mass index 30), overweight (body mass index 25–
29.9), and normal weight (body mass index <25) and time
to incident heart failure (22). All statistical analyses were
performed using SAS software, version 9.1 (SAS Institute
Inc., Cary, North Carolina).
Bootstrapping was used to estimate 95% simulation in-
tervals for the GIF and AF (23). Ten thousand bootstrapped
simulations (with replacement) were performed for each
subgroup of race, gender, and age. Each sampled data set
was the same size as the subgroup in the original data set.
The overall GIF for each scenario was determined for each
bootstrapped sample using equation 2 (10).
RESULTS
There were 3,887 obese, 5,787 overweight, and 4,968
normal-weight participants in the ARIC cohort at baseline
(Table 1). Obese participants were more often black or fe-
male, more often had less than a high school education, and
were more likely to have diabetes or hypertension. Further-
more, they were less likely to be smokers or current drinkers
of alcohol. Prevalent coronary heart disease was less com-
mon among normal-weight participants than among those
who were overweight or obese.
Themain components of the GIF equation, alongwith heart
failure incidence rates, are shown by subgroup in Table 2.
Across all race and gender groups, the incidence rates of heart
failure were at least 2 times larger for older subgroups than
for younger subgroups. Older black women and men had
particularly high heart failure incidence rates (14.0/1,000
person-years and 15.2/1,000 person-years for women and
men, respectively). For all strata, the unadjusted hazard ratios
and their 95% confidence intervals for obesity as compared
with normal weight were above 1.0, representing a harmful
association of obesity with incidence of heart failure. Hazard
ratios for heart failure were particularly high among young
white women (hazard ratio (HR) ¼ 4.14, 95% confidence
interval (CI): 2.70, 6.36). In most cases, the hazard ratios for
overweight showed an intermediate adverse association with
heart failure. However, 2 of the hazard ratios for the compar-
ison of overweight persons with the referent group were less
than 1.0 (for young blackmen,HR¼ 0.93, 95%CI: 0.49, 1.73;
for young black women, HR ¼ 0.94, 95% CI: 0.52, 1.69).
The Healthy People 2010 goal of reducing obesity to 15%
among the US adult population is similar to our goal here of
a 30% reduction in the proportion obese (Appendix Table 1).
In most subgroups, a hypothetical 30% reduction in obesity
resulted in a prevalence of obesity of 15%–19% in the pop-
ulation of interest. Black women were the exception, since
there would be a prevalence of obesity of 33%–34% for
black women even after a 30% reduction in obesity.
The median GIF (with 95% simulation intervals) for
a 30% reduction in obesity from 10,000 bootstrapped data
sets ranged from 4% to 11% for the 8 subgroups (Appendix
Table 1). The 2.5% tail of the distribution of median GIF
was actually negative for older black men.
The overall median GIFs (with 95% simulation intervals)
for 10 different scenarios of weight reduction are shown in
Figure 1 and Appendix Table 2. The overall median GIF for
the scenario of a 30% reduction in the proportion obese
(scenario 6) was 6.7% (95% simulation interval: 5.4, 8.0).
This can be interpreted to mean that 6.7% of incident heart
failure could be prevented in this population with a 30%
reduction in obesity, assuming weight loss down to the nor-
mal weight category. The most aggressive weight reduction
scenario assumed here, other than complete elimination of
obesity/overweight as required in calculation of the AF, was
a 30% reduction in obesity and overweight down to the
normal weight category (scenario 8, Figure 1). We predict
that scenario 8 would result in the prevention of 8.5% (95%
simulation interval: 6.1, 10.7) of incident heart failure
events. The last 2 scenarios represent the AF, which assumes
complete elimination of obesity and overweight in the case
of the 10th scenario, whereas the ninth scenario assumes
complete elimination of obesity only. The AF (scenario
10) is approximately 3 times larger than the GIF from the
other most aggressive scenario of weight reduction pre-
sented here (scenario 8). As would be expected, there are
increases in the GIF when persons who are obese and have
lost weight are shifted to normal weight (scenarios 2 and 6)
rather than overweight (scenarios 1 and 5).
DISCUSSION
We examined the possible public health impact on heart
failure incidence given multiple hypothetical and feasible
reductions in obesity and/or overweight, and found that the
practical level of impact appears important. We estimated
that a 30% reduction in obesity with presumed weight loss
to the normal weight category, the goal most similar to the
Healthy People 2010 goal of 15% prevalence of obesity,
would hypothetically result in 6.7% fewer incident heart
failure events. It is estimated that there are approximately
660,000 incident heart failure events annually in the United
States (1). The average cost per hospital discharge for heart
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failure (estimated from 2003 data) is $6,577 (1). To extrap-
olate our findings to the entire United States using these
estimates, a 6.7% reduction in heart failure would result in
44,220 fewer incident heart failure events expected annu-
ally, with an estimated annual cost savings of $477,674,356.
Because of the high prevalence of heart failure and the
frequent need for rehospitalization, such an impact would
offer important reductions in disease burden and health-care
utilization. Although not accounted for in these calculations,
population-wideweight reduction should also have a preven-
tive effect on common heart failure risk factors, such as
hypertension (24) and diabetes (25), resulting in further re-
ductions in health-care cost and utilization.
Caution should be taken in assuming a causal association
for obesity determined from observational studies (26). Al-
though this measure clearly has limitations in assuming
a causal association between exposure and disease, as well
as the presumed impact of a hypothetical intervention, we
pose this method as a comparison with the common practice
of estimating the AF, for which these assumptions are the
same.
Another goal from Healthy People 2010 is to increase the
percentage of the population that is normal weight to 60%
(21). Even with a 30% reduction in overweight and obesity,
this goal will not be achieved (data not shown); instead the
percentage of normal weight after a 30% reduction in obe-
sity and overweight would be 43%–54% per subgroup, ex-
cept among white women, in whom it would be 61%–65%.
Currently, more widespread weight reduction than 30%
would be needed to accomplish this goal among race and
gender groups other than white women.
The GIF estimates shown here are relatively small com-
pared with the much higher estimate of 28% for the AF. As
comparedwith the AF, theGIF is ameasure of the preventable
burden of disease that can be based on multiple hypothetical
changes in the exposure distribution. Although not shown
here, the GIF can also be used to predict the effect of a given
shift in the distribution of a continuous exposuremeasurement
(27). The AF can be thought of as simply the maximum GIF
(11). To date, the GIF has not been used elsewhere to describe
the preventable burden of heart failure due to obesity. How-
ever, researchers in 2 other studies have calculated the AF
Table 1. Characteristics of the Study Population (n¼ 14,642) at Baseline, by Category of Body












Mean BMI (SD) 22.5 (1.8) 27 (1.4) 34 (4.3)
Mean age, years (SD) 54 (6) 54 (6) 54 (6)
Male gender, % 37 56 39
Black race, % 18 25 39
Study center, %
Jackson, Mississippi 15 22 36
Forsyth County, North Carolina 34 25 17
Minneapolis, Minnesota 27 28 21
Washington County, Maryland 24 25 26
Educational level, %
Less than high school 18 23 30
High school graduate 34 31 32
More than high school 48 46 38
Smoking status, %
Never smoker 39 40 48
Former smoker 28 36 33
Current smoker 33 24 19
Alcohol consumption, %
Never drinker 21 23 34
Former drinker 16 18 21
Current drinker 63 59 45
Diabetes mellitus, % 5 10 21
Hypertension, % 21 32 49
History of coronary heart disease, % 3 5 5
Abbreviations: BMI, body mass index; SD, standard deviation.
a Weight (kg)/height (m)2.
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(5, 28). First, in the FraminghamHeart Study, Kenchaiah et al.
(28) estimated that the AF for heart failure was 14% for over-
weight women, 13.9% for obesewomen, 8.8% for overweight
men, and 10.9% for obese men. They used an equation for the
AF that is appropriate when the relative risk has been adjusted
for confounders. The Framingham population has a lower
prevalence of obesity than the ARIC population; furthermore,
Kenchaiah et al. adjusted for factors lying along the causal
pathway between obesity and heart failure (causal intermedi-
ates), which lowers the magnitude of the effect estimate. Sec-
ondly, in the First National Health and Nutrition Examination
Survey, He et al. (5) calculated the AF of heart failure for
overweight persons (5.6% in men, 9.6% in women); however,
they dichotomized body mass index at 27.8 for men and 27.3
for women. In both studies, confidence intervals for AF were
not estimated. These estimates of AF are lower than those
estimated here. This is partly due to differences in the preva-
lence of obesity and overweight in the populations and the
magnitude of the relative estimate of effect. In addition, the
method used here was based on stratified analysis; therefore,
wewere unable to control for numerous confounders, aswould
be possible from a regression-based approach.
There are several assumptions of the GIF and the AF (11).
The relative risk, or in this case hazard ratio, must be a valid
estimate of the causal relation between an exposure and a dis-
ease for the desired target population and not be biased by
confounding or misclassification. In this case, we estimated
the relation between obesity and heart failure from a longitu-
dinal observational study, and clearly there was potential for
unmeasured confounding. In addition, we extrapolated from
our study population, the ARIC cohort, to the US general
population, our target.Although itwas not donehere,wecould
have standardized the data to the US general population by
using the exposure distribution from the US population. In
addition, we assumed that persons who were hypothetically
shifted (obese) to a different risk group (normal weight or
overweight) after intervention would have the same level of
risk that their new risk group had before intervention. We
assumed that persons who lost weight would have the same
risk of heart failure as those who were normal weight without
intervention. When this condition is not met, the GIF and the
Table 2. Incidence Rates of Heart Failure and Unadjusted Hazard Ratios for Incident Heart Failure According to Body Mass Index Category, by






Rate per 1,000 Person-Years
BMIa Category








<55 3,079 2.59 0.29 1.52 0.92, 2.51 0.21 4.14 2.70, 6.36
55 2,580 6.54 0.32 1.56 1.31, 2.14 0.23 2.58 1.89, 3.53
Black women
<55 1,423 6.07 0.35 0.94 0.52, 1.69 0.47 1.63 0.96, 2.76
55 927 14.04 0.34 1.04 0.62, 1.72 0.48 1.75 1.10, 2.77
White men
<55 2,476 4.19 0.51 1.65 1.03, 2.64 0.22 2.64 2.01, 3.25
55 2,659 11.59 0.51 1.09 0.85, 1.40 0.22 1.98 1.51, 2.59
Black men
<55 830 6.46 0.44 0.93 0.49, 1.73 0.28 2.10 1.16, 3.80
55 669 15.23 0.39 1.12 0.72, 1.76 0.26 1.58 1.00, 2.49
Abbreviations: BMI, body mass index; CI, confidence interval; HR, hazard ratio.
a Weight (kg)/height (m)2.
Scenario for Reduced Prevalence of 
Overweight and Obesity
























Figure 1. The median generalized impact fraction and attributable
fraction (with 2.5%–97.5% simulation intervals) derived from 10,000
bootstrap data sets using the case-load weighted-sum method, given
10 scenarios of reduced prevalence of obesity and overweight, Ath-
erosclerosis Risk in Communities Study, 1987–2003. Scenarios for
the reduced prevalence of overweight and obesity are as follows:
1) 15% reduction in obesity, shift obese to overweight; 2) 15% re-
duction in obesity, shift obese to normal weight; 3) 15% reduction in
obesity and overweight, shift down 1 category; 4) 15% reduction
in obesity and overweight, down to normal weight; 5) 30% reduction
in obesity, shift obese to overweight; 6) 30% reduction in obesity, shift
obese to normal weight; 7) 30% reduction in obesity and overweight,
shift down 1 category; 8) 30% reduction in obesity and overweight,
shift to normal weight; 9) attributable fraction, complete elimination of
obesity; 10) attributable fraction, complete elimination of obesity and
overweight. Bars, 95% simulation interval.
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AF may overestimate the impact of an intervention. Hernán
and Taubman (26) discussed issues related to assuming a hy-
pothetical intervention for obesity without specifying the in-
tervention; althoughwe donot specify the type of hypothetical
intervention here, neither do most other investigators in esti-
mating the AF. In addition, it is assumed that there are not
secular trends indisease risk that are not due to the intervention
and there are not secular trends in intermediary diseases, such
asdiabetes, thatwould affect the relationbetween the exposure
and disease. Secular trends clearly show increasing incidence
of heart failure, obesity, and diabetes (1), which is one reason
primary prevention has become vital. Although all of these
criteria are not easily met, these are the same assumptions
made when estimating the often-used AF.
Limitations of this analysis and the GIF in general include
the fact that an adjusted effect measure cannot be used in the
GIF formula; rather, one must stratify by important con-
founders and use the crude effect measure for each stratum.
Therefore, strata with small sample sizes can be a problem.
This is not the case for the AF, as there are formulas using
an adjusted relative measure of effect (29). This is less likely
to have been a problem in the current study, as there were
few statistical confounders identified using a 10% change-
in-estimate criterion (20). In addition, it is difficult to deter-
mine feasible goals for population-wide weight reduction
(30); however, a spectrum of weight loss goals was consid-
ered here, with the Healthy People 2010 goals (21) being the
most optimistic. The GIF is subject to the same limitations as
the AF. Discretion should be used when applying and inter-
preting both measures. Furthermore, Greenland and Robins
(31) recognized 3 distinct quantities known as the AF: the
etiologic fraction of the exposed cases, the excess fraction of
the exposed risk or cases, and the incidence density fraction.
The AF quantity estimated here is akin to the incidence den-
sity fraction. More precisely, it is the hazard fraction, the
hazard being the theoretical limit of the incidence density
as the follow-up period approaches zero. It should be recog-
nized that all of these AF measures may differ in magnitude.
The incidence density fraction may approximate the excess
fraction for rare diseases and therefore the hazard fraction, if
the hazard remains approximately constant within covariate
strata over the follow-up period. Without very strong, usually
untestable, and often implausible assumptions, none of these
measures approximates the etiologic fraction (32).
For the special cases in which a percentage of both over-
weight and obese persons is shifted to normal weight, the
GIF could be calculated as that percentage of the AF. For
example, with a 30% reduction in obesity and overweight
with weight loss down to normal weight (scenario 8), the
GIF is 8.4, which is the same as 30% of the AF of 28%
(scenario 10). This is not surprising here, as the same for-
mula and stratification variables were used to calculate both
AF and GIF. More commonly, the AF is calculated with an
equation allowing inclusion of a multivariable-adjusted ef-
fect estimate, whereas there is no such equation for GIF.
Therefore, GIF calculation using the percentage of AF will
not be accurate for most published estimates of the AF.
In 1982, Morgenstern and Bursic illustrated the use of the
GIF with an example of the impact of a hypothetical weight
loss program on the incidence of coronary heart disease
(11). Similarly, we estimated the effect of reduction in obe-
sity on the burden of heart failure. These examples show
how the GIF could be used in the epidemiologic literature
for risk factors that are unlikely to be completely eradicated.
For common risk factors such as obesity and overweight, the
impact of intervention may reveal important changes in the
burden of disease even when risk factor-disease associations
are relatively weak. We suggest that investigators consider
estimating the GIF instead of, or alongside of, the AF, in
order to avoid estimates of population impact based on goals
that are unlikely to be achieved given available prevention
or treatment methods. Such evaluations are vital in order to
inform and prioritize future prevention programs regarding
the possible impact of intervention efforts.
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APPENDIX
Equation 1: GIF per stratum
The generalized impact fraction (GIF) for a given boot-













GIF ¼ generalized attributable fraction for 1 bootstrap
sample, from a given stratum of a, b, c;
Pi ¼ proportion of the population in exposure category i;
HR ¼ hazard ratio;
Pi* ¼ proportion of the population in exposure category
i after an intervention or other change;
HRi ¼ crude hazard ratio in exposure category i as com-
pared with the reference level;
i ¼ normal weight, overweight, or obese status as defined
by bodymass index (weight (kg)/height (m)2) category; and
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abc ¼ stratum of age (<55 years or 55 years), race (black












Pnormal wt;abc 3 1


ðP*overwt;abc 3HRoverwt;abcÞ þ ðP*obese;abc 3HRobese;abcÞ
þ ðP*normal wt;abc 3 1Þ
and
Denominator: GIFa;b;c ¼ ðPoverwt;abc 3HRoverwt;abcÞ
þ ðPobese;abc 3HRobese;abcÞ þ ðPnormal wt;abc 3 1Þ
:
Equation 2: case-load weighted sum method for
GIFoverall
Numerator: GIFoverall ðor AFoverallÞ for a given
bootstrap sample ¼ ð#casesa1b1c1 3 GIFa1b1c1Þ
þ ð#casesa1b1c0 3GIFa1b1c0Þ þ ð#casesa0b1c1 3GIFa0b1c1Þ
þ ð#casesa0b1c0 3GIFa0b1c0Þ þ ð#casesa0b1c1 3GIFa0b1c1Þ
þ ð#casesa0b1c0 3GIFa0b1c0Þ þ ð#casesa1b0c1 3GIFa1b0c1Þ
þ ð#casesa1b0c0 3GIFa1b0c0Þ þ ð#casesa1b0c1 3GIFa0b0c1Þ
þ ð#casesa0b0c0 3GIFa0b0c0Þ þ ð#casesa0b0c1 3GIFa0b0c1Þ
þ ð#casesa0b0c0 3GIFa0b0c0Þ
and
Denominator: GIFoverall ðor AFoverallÞ for a given





where AF ¼ attributable fraction.
Equation 3: AF, or maximum GIF, per stratum
The AF (or maximum GIF) for a given bootstrap sample
from stratum a, b, c is
hX





where pdi ¼ proportion of total cases arising from
the ith exposure category and HRi ¼ unadjusted HR
for the ith exposure category in comparison with
the reference category (i ¼ overweight or obese vs.
normal).
Appendix Table 1. Median Proportion of Subjects in Each Body Mass Index Category and Median Generalized
Impact Fraction (With 2.5%–97.5% Simulation Intervals) for Heart Failure Derived From 10,000 Bootstrapped Data


















<55 0.29 0.21 0.15 11 8, 15 13.5 8.6, 18.3
55 0.32 0.23 0.16 7 5, 10 10.5 6.7, 14.4
Black women
<55 0.35 0.47 0.33 7 0.5, 13 6.7 4.4, 16.4
55 0.34 0.48 0.34 8 2, 13 8.2 1.1, 16.1
White men
<55 0.51 0.22 0.16 8 5, 11 13.6 7.2, 20.0
55 0.51 0.22 0.15 5 3, 7 6.1 1.6, 10.4
Black men
<55 0.44 0.28 0.19 7 2, 13 6.6 4.4, 16.0
55 0.39 0.26 0.18 4 0.1, 8 5.0 2.6, 11.9
Abbreviations: BMI, body mass index; GIF, generalized impact fraction; SI, simulation interval.
a A 30% reduction in obesity to normal weight, shift all to normal weight.
b A 30% reduction in obesity and overweight with reduction to normal weight, shift all to normal weight.
c Weight (kg)/height (m)2.
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Appendix Table 2. Median Generalized Impact Fraction and Attributable Fraction (With 2.5%–97.5% Simulation
Intervals) for Heart Failure Derived From 10,000 Bootstrapped Data Sets Using the Case-Load Weighted-Sum












1 15% reduction in obesity, shift obese to overweight 2.9 2.3, 3.5
2 15% reduction in obesity, shift obese to normal weight 3.4 2.7, 4.0
3 15% reduction in obesity and overweight, shift both down 1 category 3.7 3.0, 4.5
4 15% reduction in obesity and overweight, shift both to normal weight 4.2 3.0, 5.4
5 30% reduction in obesity, shift obese to overweight 5.7 4.6, 7.0
6 30% reduction in obesity, shift obese to normal weight 6.7 5.4, 8.0
7 30% reduction in obesity and overweight, shift both down 1 category 7.4 6.0, 9.0
8 30% reduction in obesity and overweight, shift both to normal weight 8.5 6.1, 10.7
9 Complete elimination of obesity, shift to normal weight 22.0 18.0, 27.0
10 Complete elimination of obesity and overweight, shift to normal weight 28.0 20.0, 36.0
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